Radiopharmaceutical publicly funded in some provinces has fewer side effects than chemotherapy and can increase survival by about half a year

Dr. Patrick Veit-Haibach, deputy radiologist-in-chief and nuclear medicine physician at University Health Network, stands next to the door leading to an MRI machine at Toronto General Hospital in Toronto, on March 26.

The last type of chemotherapy that David Easton tried in his five-year fight against prostate cancer left him living a life that was really no life at all.

The retired Ontario autoworker slept 20 hours a day. His little time awake was spent hunched on or over the toilet at his home in Ayton, a small community about two hoursnorthwest of Toronto.

From The Globe and Mail via this RSS feed